Gainplan’s Clover Health Investments CLOV Stock Holding History

Gainplan’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,205	Closed	-$8.1K	–	68
2024 Q1	$8.1K	Sell	10,205 -2,194	-18%	-$2K	﹤0.01%	70
2023 Q4	$11.8K	Sell	12,399 -5,153	-29%	-$5.06K	0.01%	50
2023 Q3	$19K	Buy	+17,552	New	+$20.9K	0.03%	42
2023 Q2	–	Sell	-10,892	Closed	-$9.21K	–	48
2023 Q1	$9.21K	Buy	10,892 +882	+9%	+$966	0.01%	41
2022 Q4	$9.3K	Buy	+10,010	New	+$13.4K	0.02%	36
2022 Q3	–	Sell	-31,841	Closed	-$58K	–	28
2022 Q2	$58K	Sell	31,841 -13,926	-30%	-$37K	0.04%	37
2022 Q1	$162K	Buy	45,767 +13,457	+42%	+$39K	0.12%	48
2021 Q4	$120K	Sell	32,310 -3,038	-9%	-$18.6K	0.05%	60
2021 Q3	$245K	Buy	35,348 +14,689	+71%	+$126K	0.11%	49
2021 Q2	$267K	Buy	+20,659	New	+$203K	0.11%	65

Other funds holding CLOV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Susquehanna International Group

Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return

Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return